Osteoarthritis Pain Global Clinical Trials Review, H1, 2018

Date: April 25, 2018
Pages: 416
Price:
US$ 2,500.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: O015564A483EN
Leaflet:

Download PDF Leaflet

Osteoarthritis Pain Global Clinical Trials Review, H1, 2018
Osteoarthritis Pain Global Clinical Trials Review, H1, 2018

SUMMARY

GlobalData's clinical trial report, “Osteoarthritis Pain Global Clinical Trials Review, H1, 2018' provides an overview of Osteoarthritis Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Osteoarthritis Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

SCOPE
  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

REASONS TO BUY
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

NOTE: Out of security concerns GlobalData requires using corporate email address.
Report Guidance
GlobalData Clinical Trials Report Coverage
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Osteoarthritis Pain to Central Nervous System Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Osteoarthritis Pain to Central Nervous System Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Osteoarthritis Pain Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Osteoarthritis Pain
Apr 19, 2018: Centrexion Therapeutics Announces CNTX-4975 Clinical Data Presentation at the 34th Annual American Academy of Pain Medicine Meeting
Apr 19, 2018: Centrexion Therapeutics Announces CCR2 antagonist CNTX-6970 Clinical Data Presentation at the 34th Annual American Academy of Pain Medicine Meeting
Apr 18, 2018: Flexion Therapeutics Announces Publication of Results from Pivotal Phase 3 Study of ZILRETTA (triamcinolone acetonide extended-release injectable suspension) in the Journal of Bone and Joint Surgery
Apr 03, 2018: Ampio Updates Regulatory and Clinical Activities
Mar 28, 2018: MiMedx Enrolls First Patient In Its Phase 2B Clinical Trial Of RMAT Designated AmnioFix Injectable For The Treatment Of Osteoarthritis Of The Knee
Mar 06, 2018: Flexion Therapeutics Presents Clinical Data at AAOS 2018 Annual Meeting and the American Pain Society Annual Scientific Meeting
Mar 01, 2018: Paradigm Reports Osteoarthritis Pain Reduced by 50%
Mar 01, 2018: Centrexion Therapeutics to Present CNTX-4975 Clinical Data at the American Academy of
Orthopaedic Surgeons 2018 Annual Meeting
Feb 21, 2018: Centrexion Therapeutics Announces First Patient Dosed in Phase 3 Trial of CNTX-4975 f or t he Treatment of Moderate to Severe Knee Osteoarthritis Pain
Feb 06, 2018: Symic Bio Completes the MODIFY2 Phase 2 Trial of SB-061 for the Treatment of Knee Osteoarthritis
Clinical Trial Profile Snapshots
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Source

LIST OF TABLES

Osteoarthritis Pain Therapeutics, Global, Clinical Trials by Region, 2018
Osteoarthritis Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018
Osteoarthritis Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018
Osteoarthritis Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018
Osteoarthritis Pain Therapeutics Clinical Trials, Europe, Top Five Countries, 2018
Osteoarthritis Pain Therapeutics Clinical Trials, North America, Top Countries, 2018
Osteoarthritis Pain Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018
Osteoarthritis Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018
Proportion of Osteoarthritis Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2018
Osteoarthritis Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2018
Osteoarthritis Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018
Proportion of Osteoarthritis Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2018
Osteoarthritis Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2018
Osteoarthritis Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018
Osteoarthritis Pain Therapeutics, Global, Clinical Trials by Phase, 2018
Osteoarthritis Pain Therapeutics, Global, Clinical Trials In Progress by Phase 2018
Osteoarthritis Pain Therapeutics, Global, Clinical Trials by Trial Status, 2018
Osteoarthritis Pain Therapeutics Clinical Trials, Global, by End Point Status, 2018
Osteoarthritis Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017
Osteoarthritis Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018
Osteoarthritis Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2018
Osteoarthritis Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018
Osteoarthritis Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018

LIST OF FIGURES

Osteoarthritis Pain Therapeutics, Global, Clinical Trials by Region (%), 2018
Osteoarthritis Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018
Osteoarthritis Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018
Osteoarthritis Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018
Osteoarthritis Pain Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018
Osteoarthritis Pain Therapeutics Clinical Trials, North America, Top Countries (%), 2018
Osteoarthritis Pain Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018
Osteoarthritis Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018
Proportion of Osteoarthritis Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2018
Osteoarthritis Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2018
Osteoarthritis Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018
Proportion of Osteoarthritis Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2018
Osteoarthritis Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2018
Osteoarthritis Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018
Osteoarthritis Pain Therapeutics, Global, Clinical Trials by Phase (%), 2018
Osteoarthritis Pain Therapeutics, Global, Clinical Trials In Progress by Phase, 2018
Osteoarthritis Pain Therapeutics, Global, Clinical Trials by Trial Status, 2018
Osteoarthritis Pain Therapeutics Clinical Trials, Global, by End Point Status, 2018
Osteoarthritis Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017
Osteoarthritis Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018
Osteoarthritis Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2018
Osteoarthritis Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018
Osteoarthritis Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018
GlobalData Methodology

COMPANIES MENTIONED

Eli Lilly and Co
Mundipharma International Ltd
Johnson & Johnson
Pfizer Inc
C. H. Boehringer Sohn AG & Co KG
Novartis AG
Merck & Co Inc
GlaxoSmithKline Plc
Iroko Pharmaceuticals LLC
Flexion Therapeutics Inc
Skip to top


Osteoarthritis Global Clinical Trials Review, H2, 2016 US$ 2,500.00 Nov, 2016 · 918 pages
Osteoarthritis Global Clinical Trials Review, H1, 2018 US$ 2,500.00 Apr, 2018 · 1155 pages

Ask Your Question

Osteoarthritis Pain Global Clinical Trials Review, H1, 2018
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: